New depression combo shows promise in Head-to-Head trial
NCT ID NCT06957223
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study tested whether a combination of two drugs (dextromethorphan and bupropion) works better than standard antidepressants (SSRIs) for adults with major depression. 80 participants were randomly assigned to one of the two treatments for 6 weeks. The goal was to see if the new combo could improve depression symptoms and lead to remission more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Combined Military Hospital
Nowshera, KPK, 25770, Pakistan
-
Department of Psychiatry, Combined Military Hospital Nowshera
Nowshera, KPK, 25770, Pakistan
Conditions
Explore the condition pages connected to this study.